Related Experiment Video
Updated: Dec 14, 2025

Complete and Partial Resuscitative Endovascular Balloon Occlusion of the Aorta for Hemorrhagic Shock
Published on: May 19, 2022
Rectus sheath hematoma following enoxaparin administration
Ryan E Dean1, Ganesh Maniam1, Thien Vo1
1Department of Internal Medicine, Texas Tech University Health Sciences CenterAmarilloTexas.
Low-molecular-weight heparin like enoxaparin is a common thromboprophylaxis. A rare case of epigastric artery rectus sheath hematoma after enoxaparin injection led to multiorgan failure.
Area of Science:
- Internal Medicine
- Pharmacology
- Vascular Surgery
Background:
- Low-molecular-weight heparin (LMWH), such as enoxaparin, is a widely used anticoagulant for thromboprophylaxis.
- Enoxaparin offers comparable efficacy to unfractionated heparin with a reduced risk profile, making it a first-line treatment option.
Observation:
- This report details a rare case of epigastric artery rectus sheath hematoma.
- The hematoma occurred subsequent to an enoxaparin injection.
Findings:
- The rectus sheath hematoma resulted in hemorrhagic shock.
- Hemorrhagic shock led to secondary multiorgan failure in the patient.
Implications:
- This case highlights a rare but severe complication associated with enoxaparin therapy.
- Awareness of this potential adverse event is crucial for prompt recognition and management by clinicians.
- Early diagnosis and intervention are key to improving outcomes in patients presenting with similar hematoma complications.
Related Concept Videos
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis I: Introduction
Pulmonary Embolism III: Nursing Management

